OncoMed is a biotechnology company that engages in developing and commercializing novel therapeutics for the treatment of cancer... Read more
OncoMed is a biotechnology company that engages in developing and commercializing novel therapeutics for the treatment of cancer... Read more
News
Jun 22, 2020
The Business Journals: San Jose
OncoMed Pharmaceuticals: 'Natural killers' against cancer bolster Peninsula biotech's $100M IPO filing
Jun 19, 2020
The Business Journals: San Francisco Business Times
OncoMed Pharmaceuticals: 'Natural killers' against cancer bolster Peninsula biotech's $100M IPO
Jun 15, 2019
Pharmabiz
OncoMed Pharmaceuticals: Mereo BioPharma updates on its Etigilimab partnership
Apr 24, 2019
FirstWord Pharma
OncoMed Pharmaceuticals: Mereo BioPharma Group plc ("Mereo" or the "Company" or the "Group") Admission to trading on AIM of New Shares and initiation of trading on Nasdaq of American Depositary Shares
Apr 18, 2019
PMLiVE
OncoMed Pharmaceuticals: Mereo's shareholders back OncoMed takeover
Mar 15, 2019
StreetInsider
OncoMed Pharmaceuticals: OncoMed Pharma (OMED) Declares Special Dividend of Contingent Value Rights
Mar 15, 2019
Market Exclusive
OncoMed Pharmaceuticals: ONCOMED PHARMACEUTICALS, INC. (NASDAQ:OMED) Files An 8-K Entry into a Material Definitive Agreement
Mar 14, 2019
sharecast
OncoMed Pharmaceuticals: Mereo BioPharma merger with OncoMed moves closer
Mar 07, 2019
streetinsiderhttp://www.oncomed.com/
Press Release: OncoMed Pharmaceuticals : OncoMed Announces Fourth Quarter and Full Year 2018 Financial Results
Feb 22, 2019
FE Investegate
OncoMed Pharmaceuticals: Mereo BioPharma Grp : Update on Proposed Transaction with OncoMed
OncoMed Pharmaceuticals Competitors
1
2
3
4
5
6
7
8
9
10